채용
岗位职责:
- 负责工厂体系文件的维护与更新,确保体系的正常运行;
- 负责偏差、变更、CAPA和质量风险管理等合规审核;
- 负责协助外部客户与药监机构的检查工作,及回复和整改;
- 负责组织偏差审核会议、变 更审核会议,并反馈审核结果;
- 负责支持定期质量管理评审,分析质量体系数据;
- 负责支持质量电子系统的上线,以及相关的质量项目的完成;
- 负责根据新颁布法律法规的差异分析结果进行体系优化;
- 协助工厂项目注册申报工作;
- 完成上级领导交付的其他工作。
任职要求:
- 本科及以上学历,生物工程、生物技术及其他制药相关专业;
- 生物制药行业质量管理相关工作5年以上;
- 英文CET-4以上,具备良好听说读写能力。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고

Engineering Technician III
Applied Materials · Xi'an,CHN

(Sr./Expert/Sr. Expert )Technician-QC-Chemical
Eli Lilly · China, Suzhou Manufacturing-苏州工厂

Sr. Manufacturing Engineer
Thermo Fisher · Guangdong, China

(Sr./Principal) Biologist-QC
Eli Lilly · China, Suzhou Manufacturing-苏州工厂

设备维修保养技术员(机器人车间)
ABB · Shanghai, Shanghai, China
BioNTech 소개

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
4d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
1w ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
1w ago